Class Action Filed Against Hims & Hers Health, Inc. (HIMS) - August 25, 2025 Deadline to Join - Contact The Gross Law Firm

Core Viewpoint - Hims & Hers Health, Inc. is facing allegations of deceptive practices related to the promotion and sale of illegitimate versions of Wegovy®, which may jeopardize its collaboration with Novo Nordisk and mislead investors about the company's operations and prospects [2]. Group 1: Allegations and Class Action Details - The class period for the allegations is from April 29, 2025, to June 23, 2025 [2]. - Allegations include that Hims engaged in deceptive promotion and selling of knockoff versions of Wegovy®, risking patient safety [2]. - The complaint suggests that the misleading statements from the company could lead to the termination of its collaboration with Novo Nordisk [2]. Group 2: Shareholder Information - Shareholders are encouraged to register for the class action by August 25, 2025, to potentially become lead plaintiffs [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [3]. - Participation in the case incurs no cost or obligation for shareholders [3]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [4].